Search

Your search keyword '"Yao, Jiqiang"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Yao, Jiqiang" Remove constraint Author: "Yao, Jiqiang"
159 results on '"Yao, Jiqiang"'

Search Results

1. Author Correction: Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src

2. Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src

3. Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy

4. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

6. Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic HSCT Patients

8. Characterization of Capsicum annuum genetic diversity and population structure based on parallel polymorphism discovery with a 30K unigene Pepper GeneChip.

9. De novo assembly of the pepper transcriptome (Capsicum annuum): a benchmark for in silico discovery of SNPs, SSRs and candidate genes

10. Comprehensive genomic characterization defines human glioblastoma genes and core pathways

13. Data from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

14. Supplementary Figures S1-S7 and Supplementary Methods from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

15. Supplementary Tables S1 to S10 from Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

17. Association between CYP3A4, CYP3A5and ABCB1genotype and tacrolimus treatment outcomes among allogeneic HSCT patients

19. 'Alterations in the Skin Microbiota Are Associated With Symptom Severity in Mycosis Fungoides'

20. The Fusarium graminearum Genome Reveals a Link between Localized Polymorphism and Pathogen Specialization

24. Abstract 1635: Sirt2 blockade promotes T cell metabolism and restores the anti-tumor immunity

26. Fucosylated Proteome Profiling Identifies a Fucosylated, Non-Ribosomal, Stress-Responsive Species of Ribosomal Protein S3

27. A Mutational Survey of Acral Nevi

28. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

29. Somatic mutations affect key pathways in lung adenocarcinoma

31. 280 Both tumor intrinsic and extrinsic factors contribute to TIL resistance in lung cancer patients

32. 93 Targeting sirt2 rescues the metabolic fitness and effector functions of tumor-reactive T cells within the metabolically restricted tumor microenvironment

33. Artificial selection for host resistance to tumour growth and subsequent cancer cell adaptations: an evolutionary arms race

34. Abstract CT056: Durable complete responses to adoptive cell transfer using tumor infiltrating lymphocytes (TIL) in non-small cell lung cancer (NSCLC): A phase I trial

35. Changes in the transcriptome of morula-stage bovine embryos caused by heat shock: relationship to developmental acquisition of thermotolerance

36. Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

38. Overall responses with coordinated pembrolizumab and high dose IL-2 (5-in-a-row schedule) for therapy of metastatic clear cell renal cancer: A single center, single arm trial.

39. Eprenetapopt (APR-246) and Azacitidine in -Mutant Myelodysplastic Syndromes.

40. PrimerSNP: a web tool for whole-genome selection of allele-specific and common primers of phylogenetically-related bacterial genomic sequences

41. VitisExpDB: A database resource for grape functional genomics

42. Analysis of the genome-wide variations among multiple strains of the plant pathogenic bacterium Xylella fastidiosa

43. Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer

45. Phase 1b/2 Combination Study of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Catalog

Books, media, physical & digital resources